Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.3.2.10 extracted from

  • Liu, J.Y.; Park, S.H.; Morisseau, C.; Hwang, S.H.; Hammock, B.D.; Weiss, R.H.
    Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo (2009), Mol. Cancer Ther., 8, 2193-2203.
    View publication on PubMedView publication on EuropePMC

Inhibitors

Inhibitors Comment Organism Structure
1-(3,4-dichlorophenyl)-3-(4-phenoxyphenyl)urea
-
Homo sapiens
1-(trifluoromethoxyphenyl-3-(1-methylsulfonyl)piperidin-4-yl)urea
-
Homo sapiens
additional information no inhibition by sunitinib, another vascular endothelial growth factor receptor. The classical sEH inhibitors do not cause growth inhibition and apoptosis and do not synergize with sorafenib Homo sapiens
sorafenib a vascular endothelial growth factor receptor, inhibits sEH, effects in vivo, causes a shift in oxylipid profile and reduces the acute inflammatory response, overview. Reverses lipopolysaccharide-induced hypotension Homo sapiens
trans-4-[4-(3-adamantan-1-yl-ureido)cyclohexyloxy]-benzoic acid
-
Homo sapiens

Localization

Localization Comment Organism GeneOntology No. Textmining
soluble
-
Homo sapiens
-
-

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Synonyms

Synonyms Comment Organism
SEH
-
Homo sapiens

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
30
-
assay at Homo sapiens

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
7.4
-
assay at Homo sapiens

Ki Value [mM]

Ki Value [mM] Ki Value maximum [mM] Inhibitor Comment Organism Structure
0.000017
-
sorafenib
-
Homo sapiens